Jul 3, 2023, 18:40
We propose molecular monitoring + donor lymphocyte infusion as standard of care for relapsed myelofibrosis after BMT
In a post by Nico Gagelmann on Twitter, it says, “We propose molecular monitoring + donor lymphocyte infusion as standard of care for relapsed myelofibrosis after BMT.
- identifies patients early at molecular relapse
- achieves deep responses
- excellent outcome.”
For details: Click here
Source: Nico Gagelmann/Twitter
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 20, 2024, 02:48
Oct 20, 2024, 02:37
Oct 19, 2024, 18:58
Oct 19, 2024, 18:54
Oct 19, 2024, 18:47